期刊文献+

调强适形放疗同步化疗治疗复发性宫颈癌的效果观察 被引量:1

Observation on Curative Effects of Intensive Modulated Radiation Therapy Plus Chemotherapy in Treating Recurrent Cervical Carcinoma
下载PDF
导出
摘要 目的探究调强适形放疗同步化疗治疗复发性宫颈癌的疗效。方法选取2014年7月至2016年7月经我院化疗后复发的宫颈癌患者76例为研究对象,按照随机数字表法将其分为观察组(n=38)与对照组(n=38),对照组采用常规三维适形放疗,观察组采用调强适形放疗同步化疗,比较两组患者疗效、不良反应、近期生存率和转移率。结果观察组疗效总有效率(86.84%)显著高于对照组(63.16%),差异具有统计学意义(P=0.0171);观察组白细胞下降Ⅱ~Ⅲ的发生率(31.58%)显著低于对照组(63.16%),差异具有统计学意义(P<0.05);两组患者近期生存率和转移率比较差异无统计学意义(P>0.05)。结论调强适形放疗同步化疗治疗复发性宫颈癌疗效明确,安全性高,值得推广应用。 Objectives To study the curative effects of intensive modulated radiation therapy plus chemotherapy in treating recurrent cervical carcinoma.Methods 76 cases of patients with recurrent cervical carcinoma after chemotherapy admitted and treated in our hospital during July 2014 and July 2016 were selected as the study objectives.They were randomly divided into observation group(n=38)and contrast group(n=38).Patients in the contrast group were given conventional 3 d chemoradiotherapy,while patients in the observation group were given intensive modulated radiation therapy plus chemotherapy.Compare the curative effects,adverse reaction,current survival rate and transfer rate.Results The total effective rate in the observation group(86.84%)was significantly higher than the contrast group(63.16%).The difference showed a statistical significance(χ~2=5.6842,P=0.0171).The leukocyte decline rate in II to III stage in the observation group(31.58%)was significantly lower than the contrast group(63.16%).The difference showed a statistical significance(P〈0.05).The comparison of the current survival rate and transfer rate showed no statistical significance(P〉0.05).Conclusion Intensive modulated radiation therapy plus chemotherapy is proved to be effective in treating recurrent cervical carcinoma with high security.Thus,it deserves to be widely promoted.
作者 王辉
机构地区 睢县中医院
出处 《哈尔滨医药》 2017年第6期520-521,共2页 Harbin Medical Journal
关键词 调强适形放疗同步化疗 复发性宫颈癌 疗效 Intensive modulated radiation therapy plus chemotherapy Recurrent cervical carcinoma Curative eilects
  • 相关文献

参考文献6

二级参考文献44

  • 1杨学宁,吴一龙.实体瘤治疗疗效评价标准——RECIST[J].循证医学,2004,4(2):85-90. 被引量:1479
  • 2范立,郭汝元,高伟,米悦.三维适形放疗治疗早期宫颈癌的临床观察[J].中国药物与临床,2005,5(6):418-420. 被引量:14
  • 3车少敏,刘孜,陈宏伟,郑伟,苏进,高莹,杨蕴一.三维适形放疗治疗子宫颈癌50例近期临床观察[J].中华妇产科杂志,2007,42(11):727-729. 被引量:21
  • 4谷铣之,殷蔚伯,余子豪,等.肿瘤放射治疗学[M].3版.北京:中国协和医科大学出版社,2008:1007 -1050.
  • 5Jemal A,Bray F.MM global cancer statistics[J].CA Cancer J Clin,2011,61:69-90.
  • 6Lyman JT.Coplication probability as assessed from dose volume hiatograms[J].Radiat Res,1985,30(12):186-187.
  • 7任俊丽,范立,郑雅琴,等.子宫颈癌术后盆腔淋巴结转移三维适形与调强放疗剂量学对比研究[J].肿瘤研究与临床,2010,8(22):14-16.
  • 8Lim K,Small Jr W,Portelance L,et al. Consensus guidelines for delineation of clinical target volume for intensity- modulated pelvic radiotherapy for the definitive treatment of cervix cancer [J]. International Journal of Radiation Oncology Biology Physics,2011,79(2) :348-355.
  • 9Bansal V,Kumar G,Bhutani R,et al. Three--dimensional con- formal brachytherapy boost in locally recurrent or residual cervical carcinoma:does it impact clinical outcome? [J]. Journal of Obstetrics and Gynaecology Research, 2013,39 (1) :264-271.
  • 10Ellingsen C,Hompland T,Mathiesen B,et al. Microenvi- ronment-associated lymph node metastasis of human cervical carcinoma xenografts [J]. Acta Oncologica'2012, 51(4) :465-472.

共引文献27

同被引文献4

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部